Skip to main content

Closed

RNTX: Rein Therapeutics Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

1thpctl

Volume

0.45×avg

Market Cap

20.61MUSD

P/E Ratio

-0.4TTM

Div Yield

-ann

Rein Therapeutics Inc.

RNTXNASDAQ Global Market·USD·Closed

Rein Therapeutics Inc.

RNTXNASDAQ·USD·Closed

$0.74

−3.98%

$0.74

−$0.03 (3.98%)

52W Range

1thpctl

Volume

0.45×avg

Mkt Cap

20.61MUSD

P/E

-0.4TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings